Allergan, Inc.
Allergan reports pharmaceutical sales increased 22%
Published in Lab Business Week, June 11th, 2006
Allergan also announced that its board of directors has declared a first quarter dividend of $0.10 per share, payable on June 13, 2006 to stockholders of record on May 19, 2006.
For the quarter ended March 31, 2006 Allergan's net sales were $615.2 million, excluding sales of products acquired in the Inamed acquisition, which was completed on March 23, 2006. Pharmaceutical sales increased 22.0%, or 23.0% at constant currency, compared to pharmaceutical sales in the first quarter of 2005.
Allergan reported $3.29 diluted loss per share...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-06-11)
More Articles from Lab Business Week
- Abraxis BioScience, Inc.
Abraxis BioScience posts sales increase of 19% - Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals reports loss of $0.01 per share - Advancis Pharmaceutical Corp.
Advancis Pharmaceutical posts net loss of $0.25 per share - Akorn, Inc.
Akorn reports first quarter 2006 revenues of almost $30 million - Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals posts loss per share of $0.88 - Allergen Foundation
Allergan Foundation donates $2 million to U of California Irvine for ophthalmology research - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
